NOVAMSC (0026) Stock Overview

Nova MSC Berhad, an investment holding company, engages in the software research and development, and provision of e-business solutions in Malaysia, Singapore, and internationally. Its product portfolio includes Pavo, a software that facilities the online submission of application documents; and Fornax, an electronic plan check systems and electronic approval management software. The company also offers Vesalius, a web-based platform that supports the administrative and clinical function within a hospital, including physician support systems, nursing care, disease management, scheduling, patient registration, operating theatre management, and billing; Avicenna, an integrated cloud-based system, which manages the administrative needs and clinical aspects of patient management in a healthcare facility from a single practitioner clinic to a multi-specialist outpatient center; and EyScan, a cloud based platform, which manages and execute SELENA+ that performs automated retinal photo analysis to detect retinopathy and systemic complications in diabetic patients. In addition, it provides DEXIE, a multi-competent social robot for dementia care that supports social interactions with people with dementia in a care environment. In addition, the company provides a range of professional services, such as consultancy, training, maintenance, and customized applications software; e-business solutions for the building and construction, city, town council and telecommunications industries; information technology and consultancy services; and software consultancy and computer systems integration services.It serves various sectors including services for various sectors, including transportation, utilities, government, and healthcare. Nova MSC Berhad was incorporated in 2002 and is based in Kuala Lumpur, Malaysia.